CAS: 1672668-24-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PT2977 REF: AN-AG01V3M7CAS: 1672668-24-4 | 98% | 124.00 €~567.00 € | Tue 21 May 24 |
 | Belzutifan REF: 4Z-B-263001CAS: 1672668-24-4 | - - - | To inquire | Tue 28 May 24 |
 | Belzutifan REF: TM-T16679CAS: 1672668-24-4 | 99.34% | 69.00 €~917.00 € | Tue 28 May 24 |
 | PT2977 REF: 3D-XRC66824CAS: 1672668-24-4 | Min. 95% | 1,275.00 €~1,912.00 € | Tue 16 Jul 24 |
Ref: AN-AG01V3M7
| 25mg | 124.00 € | |
| 50mg | 150.00 € | |
| 100mg | 252.00 € | |
| 250mg | 567.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Ref: 4Z-B-263001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 May 2024
Belzutifan
CAS:1672668-24-4
Belzutifan (MK-6482) is a potential treatment for clear cell renal cell carcinoma (ccRCC). Belzutifan is …
Formula:
C17H12F3NO4S
Purity:
99.34%
Color and Shape:
Solid
Molecular weight:
383.34
Ref: TM-T16679
| 1mg | 69.00 € | |
| 5mg | 149.00 € | |
| 10mg | 269.00 € | |
| 25mg | 455.00 € | |
| 50mg | 664.00 € | |
| 100mg | 917.00 € | |
| 1ml*10 (DMSO) | 163.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
PT2977
CAS:1672668-24-4
PT2977 is a fatty acid that has potent antitumor activity. It binds to the α …
Formula:
C17H12F3NO4S
Purity:
Min. 95%
Molecular weight:
383.34 g/mol
Ref: 3D-XRC66824
| 1g | 1,275.00 € | |
| 2g | 1,912.00 € |
Estimated delivery in United States, on Tuesday 16 Jul 2024
